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heterogeneous tumors. The insert has an outer low-uptake 
volume encompassing a high-uptake inner volume. SUV ratio 
of 1:2 was intended. The second phantom accommodates 
applicators that can hold Farmer ion chamber in a location 
matching the center of the inner volume and in four locations 
matching the outer volume. 4D PET/CT scans of the phantom 
were acquired with three breathing wave forms of ideal 
sinusoid and two patient-specific breathing patterns fed to 
the moving platform. Patient-specific wavefronts were 
selected to represent a regular and an irregular breather. 
Two scenarios were investigated for image reconstruction, 
planning and delivery: a gate 30-70 window, and no gating. 
ITVs were delineated on the obtained 4D PET/CT scans and 
21 VMAT-SIB treatment plans were generated with two 
fractionation regimens: 
· Conventional fractionation: 2 Gy/fx to outer ITV, 2.4Gy/fx 
to high SUV inner ITV, 30 fx.  
· Hypo-fractionation delivered in both flattening filter and 
flattening filter free (FFF) modes: 8 Gy/fx to outer ITV, 9 
Gy/fx to inner ITV,5 fx. Treatment plans were delivered in 
two gating scenarios: no gating and gate 30-70. Two ion 
chamber readings for the inner ITV, and two readings for one 
arbitrarily selected outer ITV were acquired. Measured doses 
in the inner ITV and the outer ITV were compared to planned 
doses. 
 
Results: For both fractionation regimens and both delivery 
modes, measured doses in outer and inner ITV were between 
93 and 99% of planned doses. Measured dose as compared to 
planned dose demonstrated independence from breathing 
pattern or gating window. In particular, measured doses in 
FFF mode were consistent with measured doses in filtered 
beam mode, 94-96% of planned dose. 
 
Conclusion: The phantom has been validated for end-to-end 
use from 4D PET/CT scanning and radiotherapy planning, to 
dosimetric verification. Measured doses for SIB plans were in 
reasonable agreement for all three breathing patterns and 
for both gating windows and delivery modes. 
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Purpose or Objective: Purpose: Image guided radiotherapy 
(IGRT) is the standard treatment of prostate cancer, widely 
based on Cone Beam CT (CBCT). The accuracy of CBCT based 
prostate registration is however not well established, 
conditioning the choice of the Planning Target Volume (PTV) 
margins. The goal of the study was to quantify the 
uncertainty of this registration and propose therefore 
appropriate margins. 
 
Material and Methods: Materials and methods: A total of 306 
prostate CT to CBCT alignments were analyzed in 28 prostate 
cancer patients treated by IGRT. The prostate was manually 
delineated on all the CBCT. Three prostate alignment 
modalities were afterwards simulated and compared, based 
on skin marks, on CBCT registration performed by the 
technologist at the fraction (IGRTt) and on the prostate 
contours. The IGRT uncertainty (IU) was defined as the 
difference between the contour based and the CBCT 
alignments, in each space direction. Dice index (DI) were 
calculated. Margins were calculated, based on the IU and the 
Van Herk formula. 
 
Results: Results: The mean (min;max) absolute values of the 
IU were, in mm: 1.5 (0;10), 0.7 (0;12) and 0.9 (0;7), in 
antero-posterior (A/P), cranio-spinal (CS) and lateral 
directions, respectively. After IGRTt alignment, 25 prostate 
(11% of cases) still projected partially out of the PTV, 
corresponding to an average prostate volume (min; max) of 
2.3 cc (0.0;12.6). The mean + standard deviation of the DI 
were 0.84 + 0.08, 0.90 + 0.07 and 0.93 + 0.03 for the skin 
marks, CBCTt and contours registration, respectively. For at 
least 95% of the IGRT registrations covering 100% of the 
prostate, the required A/P, CS and lateral PTV margins (mm) 
should be at least 4.5, 2.0 and 3.0, respectively. The Van 
Herk PTV margins (mm) were 5.5, 4.1 and 3.0 in the A/P, CS 
and lateral directions, respectively. 
 
Conclusion: Conclusions: CBCT based prostate registration 
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Purpose or Objective: The aim of this study was to analise 
the patients setup errors for various tumor sites based on 
clinical data from modulated treatments using cone beam 
computed tomography (CBCT) imagine guidance and portal 
imaging for breast site. It was also calculated the planning 
target volume (PTV) margins of all disease sites and 
stipulated action level for online correction. 
 
Material and Methods: The patients analyzed in this study 
were treated in our institution between January 2012 and 
December 2014 with VMAT and IMRT via flash technique for 
breast cancer. The various tumor sites were divides into six 
categories; 175 breast (1173 fractions); 53 thorax (475 
fractions); 60 prostate (585 fractions); 100 H&N (858 
fractions); 100 SNC (789 fractions) and 77 pelvis (620 
fractions).  
For every treatment fraction, it were acquired KV-CBCT 
images using the on-board imager (OBI) (Varian Medical 
Systems), and for breast cancer it were acquired MV portal 
images using the Electronic Portal Imaging Device (EPID) 
(Siemens AG) in the first week and twice per week. The 
registration procedure was performed for all treatments sites 
according to the tumor localization. For prostate site, it was 
also analyzed the physiological state of bladder and rectum.  
It were calculated the systematic (Σ) and random (σ) errors 
of couch shift obtained, and PTV margin (2,5Σ + 0,7σ). 
 
Results: The Σ and σ for all treatment sites are summarized 
in table 1 as well PTV margins.  
Table 1. The systematic and random errors and PTV margins  
 




The largest magnitude of Σ and σ for H&N was 1.94 mm, SNC 
was 1.56 mm, breast was 1.87 mm, thorax was 3.33 mm, 
pelvis was 3.75 mm and prostate was 2.89 mm. The PTV 
margins required are <4.5 mm for brain and H&N lesions, 
<5.5 mm for breast cancers, but range from 4.5 to 9 mm for 
thorax, prostate and pelvis lesions. 
Theses values indicate the setup variations of each patient. 
The variations were smaller for the breast, SNC and H&N 
cohorts than the prostate, pelvis and thorax cohorts. The 
pelvis and breast cohorts showed the greatest variation in 
lateral direction and the prostate cohorts in vertical 
direction. The largest variation were presented in thorax 
cohorts in longitudinal direction and the lowest were in the 
SNC cohorts. 
 
Conclusion: As the setup errors vary according to each 
immobilization systems, the analysis of each institution`s 
specific setup errors is essential for determining the PTV 
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Purpose or Objective: The purpose of this project is to 
gather knowledge on the movement of pelvic lymph nodes 
relative to the prostate, seminal vesicles and bones in the 
pelvis and how this may affect the patient treatment plan.  
 
Material and Methods: Until present, 10 patients have been 
included in the study. All patients have diagnosed prostate 
cancer and were treated with radiation therapy with curative 
intent. The patients followed the normal preparation and 
treatment procedure at our clinic - however, six additional 
MRI scans were acquired (baseline: before RT, on treatment 
day 1, 3, 5, 20 and 35) see figure. In each image set, several 
structures were delineated including fiducial markers, bony 
structures and lymph nodes. A radiologist identified lymph 
nodes along the common spread paths of prostate cancer. No 
suspected pathological nodes were found. Oncentra (Elekta) 
was used for image registration. Baseline images were 
defined as reference images and all other examinations were 
registered to the reference in two separate ways; bone 
matching and fiducial markers matching. For the bone 
matching, four structures were outlined; the disc between 
S1-S2, head of the right and left femur and the pubic 
symphysis. For the fiducial marker matching, the three gold 
markers in the prostate were outlined. In both cases the 
images were manually matched. Lymph node, seminal vesicle 
and prostate movements and morphological change were 
evaluated In MATLAB. Lymph nodes were grouped into 
regions: para-aortic (PA), common iliac (CI), pre-sacral (PS), 





Results: We found that prostate moves up to 10 mm in 
anterior-posterior direction and up to 5 mm in right-left and 
cranio-caudal directions relative to bony anatomy from 
baseline scan. The lymph node group with the largest 
movements in right-left direction were CI with up to 20 mm 
difference from baseline. In the anterior-posterior and 
cranio-caudal directions, the maximum movement was 9 mm 
relative to bone from baseline scan. For the lymph nodes in 
the EI and PS regions, a significant difference was found 
depending on whether bone or fiducial markers were used for 
registration in right-left or cranio-caudal directions. In the 
other cases, no statistically significant difference between 
bone matching and fiducial marker matching was found 
 
Conclusion: Preliminary findings suggest that the pelvic 
lymph nodes are more mobile than expected, indicating the 
need to account for that in treatment planning. However, 
more patients need to be included in the study before a 
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Purpose or Objective: Optical 3D Surface Scanner (3D-OSS) is 
a simple and easily reproducible method for patient 
alignment, and is an accurate tool to show anatomical 
changes, for example, in breast locations. The aim of this 
study was to evaluate the feasibility of both achieving within 
a few minutes an 3D-OSS using a smartphone and creating an 
image fusion between this 3D-OSS and the CT scanner, in a 
simple, cheap and reliable way. 
 
Material and Methods: A smartphone and a free commercial 
app (TRNIO, www.trnio.com) were used to create an 3D-OSS. 
This app takes a series of pictures of your object as you move 
your smartphone around it. After a scan is completed, a 3D 
model will be generated on your phone. This 3D map is 
available for downloading on the TRNIO website. Although 
there are several image reconstructing algorithms available, 
in order to first show the feasibility of the method described 
here we will be using the commercial app. In the meantime, 
